Cargando…
Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia
OBJECTIVES: To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia. DESIGN: Cohort study. SETTING: Thirteen hospitals in New Jersey, United States during March to June 2020. P...
Autores principales: | Go, Ronaldo C., Shah, Roshan, Nyirenda, Themba, Oe, Yukiko, Sarfraz, Khurram, Panthappattu, Justin J., Philip, Lesley, Bheeman, Chandni, Shah, Neel, Shah, Sapan, Dar, Sophia, Hung, Sung, Rahman, Waqas, Im, Hyun, Marafelias, Michael, Omidvari, Karan, Pradhan, Anuja, Sadikot, Sean, Rose, Keith M., Sperber, Steven J., Josephs, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291358/ https://www.ncbi.nlm.nih.gov/pubmed/34291223 http://dx.doi.org/10.1097/CCE.0000000000000493 |
Ejemplares similares
-
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022) -
Racial/ethnic disparities on inflammation and response to methylprednisolone in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022) -
INITIAL, MAXIMUM, AND DELTA TROPONIN AND MORTALITY IN COVID-19
por: Go, Ronaldo, et al.
Publicado: (2021) -
TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021) -
Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022)